Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell)
MKKCT-900-002
Phase 3 mab active
Quick answer
Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell) for Respiratory Syncytial Virus (RSV) is a Phase 3 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Respiratory Syncytial Virus (RSV)
- Phase
- Phase 3
- Modality
- mab
- Status
- active